Get Started Now! Get Your Credit Repair Do It Yourself!!

WNS (NYSE:WNS) vs. Protagenic Therapeutics (NYSE:PTIX) Financial Review

New IdentityTheft Scam

WNS (NYSE:WNS) and Protagenic Therapeutics (OTCMKTS:PTIX) are both business services companies, but which is the superior stock? We will compare the two companies based on the strength of their earnings, risk, institutional ownership, profitability, analyst recommendations, valuation and dividends.

Valuation & Earnings

This table compares WNS and Protagenic Therapeutics’ gross revenue, earnings per share (EPS) and valuation.

Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio
WNS $809.10 million 3.86 $105.43 million $2.25 27.65
Protagenic Therapeutics N/A N/A -$2.56 million N/A N/A

WNS has higher revenue and earnings than Protagenic Therapeutics.


This table compares WNS and Protagenic Therapeutics’ net margins, return on equity and return on assets.

Net Margins Return on Equity Return on Assets
WNS 13.47% 23.57% 14.61%
Protagenic Therapeutics N/A -3,332.90% -346.28%

Institutional & Insider Ownership

94.7% of WNS shares are held by institutional investors. 41.0% of Protagenic Therapeutics shares are held by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock is poised for long-term growth.

Volatility and Risk

WNS has a beta of 1.15, meaning that its stock price is 15% more volatile than the S&P 500. Comparatively, Protagenic Therapeutics has a beta of -7.32, meaning that its stock price is 832% less volatile than the S&P 500.

Analyst Recommendations

This is a summary of current recommendations and price targets for WNS and Protagenic Therapeutics, as reported by

Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
WNS 0 1 8 1 3.00
Protagenic Therapeutics 0 0 0 0 N/A

WNS currently has a consensus price target of $69.60, indicating a potential upside of 11.88%. Given WNS’s higher probable upside, analysts plainly believe WNS is more favorable than Protagenic Therapeutics.


WNS beats Protagenic Therapeutics on 10 of the 11 factors compared between the two stocks.

WNS Company Profile

WNS (Holdings) Limited, a business process management company, together with its subsidiaries, provides data, voice, analytical, and business transformation services worldwide. It operates through two segments, WNS Global BPM and WNS Auto Claims BPM. The company offers industry-specific services to clients primarily in insurance; travel and leisure; diversified businesses, including manufacturing, retail, consumer packaged goods, media and entertainment, and telecommunication; utilities; consulting and professional services; healthcare; banking and financial services; and shipping and logistics industries. It also provides shared services, such as customer interaction, finance and accounting, research and analytics, technology, legal, and human resources outsourcing services. In addition, the company offers transformation services designed to help its clients to modify their business processes to enhance productivity, as well as manage changes in the business environment and leverage business knowledge to increase market competitiveness. Further, it provides claims handling and repair management services for automobile repairs through a network of third party repair centers; and a suite of accident management services, such as credit hire and credit repair. WNS (Holdings) Limited was founded in 1996 and is based in Mumbai, India.

Protagenic Therapeutics Company Profile

Protagenic Therapeutics, Inc., a biotechnology company, engages in the discovery and development of therapeutics to treat central nervous system disorders. Its lead drug candidate is PT00114, which is in clinical proof-of-concept studies for the treatment-resistant depression and/or post-traumatic stress disorder. The company is based in New York, New York.

Source: on 2019-11-04 03:29:33

Read More At Source Site

Add a Comment

Your email address will not be published. Required fields are marked *

7 + 2 =